China News
-
China Biologics appoint David Gao to additional post of CEO
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
China Biologic Products, one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, has appointed Chairman Mr David (Xiaoying) Gao to the additional pos...Read more
-
BMS pledges $15 million to help curb diabetes in India and China
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: The Bristol-Myers Squibb Foundation has expanded its Together on Diabetes initiative to China and India, pledging $15 million over five years to help these developing nations wit...Read more
-
Genetic diagnostics companies speed ahead
China | Opinion | By Nandita Singh | 0 Comment | 28 Jun, 2013
The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US Supreme Court on June 13, 2013, stating that human genes cannot be p...Read more
-
Bristol-Myers Squibb reveals new grants for Hepatitis in India, China
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, July 30, 2012: The Bristol-Myers Squibb Foundation has awarded four new grants totaling US $1.69 million to improve prevention, care and support of hepatitis B (HBV) and hepatiti...Read more
-
Tiyanyin pharma all set for GMP inspection
China | Regulatory | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2014
Singapore: China-based Tianyin Pharmaceutical is looking ahead to get its Qionglai Facility (QLF) GMP certified post insepction by China Food and Drug Administration (CFDA) expected to begi...Read more
-
Industry applauds Dr Weidong Yin
China | Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2012
"I met Dr Weidong Yin for the first time in 1996 when I went to Tangshan, China. At that time, he was involved in research. He was very young then and was running a very small scale company...Read more
-
Simcere, Zhuhai enter share transfer agreement
China | News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013
Singapore: Leading pharmaceutical company, Simcere Pharmaceutical, announced sale of equity interest in Jilin Bodapharmaceutical (Boda). The company entered into a share transfer agreement ...Read more
-
SFDA reports high chromium in Biostar's drug
China | Regulatory | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, June 01, 2012: China based Biostar Pharmaceuticals has acknowledged the finding of chromium content higher than edible gelatin from a batch of its Xin Aoxing capsules following...Read more
-
US biotech firm invests in China to enter Asia
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, June 01, 2012: GenScript, a US biotech company, has announced the opening of a new R&D facility in Nanjing, China. This new facility will play a key role in GenScript's strat...Read more
-
Ambrx, Zhejiang, WuXi to develop cancer drug in China
China | News | By BioSpectrum Bureau | 0 Comment | 17 Jun, 2013
Singapore: US-based Ambrx and China-based Zhejiang Medicine (ZMC) announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally devel...Read more
-
CCBC continues to repurchase shares
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: China Cord Blood, the first and largest cord blood banking operator in China, repurchased an aggregate of 2,191,412 ordinary shares for a total consideration of approximately $6...Read more
-
China | News | By BioSpectrum Bureau | 0 Comment | 19 Mar, 2012
"Dr Wang has great vision for Sundia and her leadership makes it possible for us to see tremendous growth. She has successfully led Sundia to navigate through the global financial crisis in...Read more
-
'China's H7N9 outbreak an epidemic'
China | News | By BioSpectrum Bureau | 0 Comment | 17 Mar, 2014
Singapore: While experts and health ministries in various Chinese provinces have declared the on-going second wave of H7N9 in the country as more destructive than the first one in early 201...Read more
